Table 2.

Peritumoral white adipose tissue cytokines and protein content (pg/mg of protein) in weight‐stable cancer patient (WSC) and in cachectic cancer patient (CC)

Protein	WSC	CC	P
IL‐6	6.85 [4.13–21.44]	8.71 [1.17–24.74]	0.75b
IL‐10	0.49 [0.27–0.79]	0.17 [0.05–0.78]	0.17b
IL‐15	1.16 ± 0.17	1.30 ± 0.19	0.57a
MCP‐1	106.30 [25.37–633.20]	90.97 [35.74–307.40]	0.69b
TNF‐α	0.57 ± 0.11	1.04 ± 0.19	0.05a
IL‐7	2.58 [2.45–4.57]	3.61 [1.90–12.95]	0.39b
IFN‐ALPHA	12.46 [5.98–86.04]	15.59 [8.97–21.02]	0.61b
IFN‐GAMMA	0.83 [0.08–2.44]	0.97 [0.62–1.75]	0.75b
IL‐1α	1.15 [0.43–2.05]	0.87 [0.12–2.06]	0.53b
IL‐1Rα	8.41 ± 2.49	15.10 ± 3.29	0.12a
IL‐2	0.36 ± 0.07	0.36 ± 0.03	0.98a
IL‐8	14.59 [6.64–29.96]	16.78 [15.41–55.35]	0.14b
IL‐17α	0.42 ± 0.06	0.40 ± 0.13	0.88a
IP‐10	12.93 [6.19–19.62]	54.17 [7.65–178.9]	0.07b
ANGPTL‐4	10029.79 ± 1168.79	8949.79 ± 1136.50	0.49a
MIP‐1α	11.44 [5.30–24.47]	14.20 [4.32–40.28]	0.85b
MIP‐1β	9.33 ± 2.01	8.53 ± 1.13	0.71a
TNF‐β	0.82 ± 0.21	0.87 ± 0.11	0.79a
IL‐12p40	5.48 ± 0.73	3.78 ± 0.41	0.04a
Il‐12p70	1.48 ± 0.22	1.20 ± 0.11	0.22a
IL‐13	6.24 ± 1.59	5.82 ± 0.78	0.79a
VEGF	14.80 ± 3.27	14.91 ± 1.17	0.97a
IL‐3	0.42 [0.18–0.88]	0.62 [0.05–1.06]	0.70b
IL‐5	0.16 ± 0.04	0.17 ± 0.02	0.81a
EOTAXIN	3.33 ± 0.51	3.20 ± 0.47	0.85a
GM‐CSF	2.76 [1.28–5.23]	1.04 [0.32–2.84]	0.13b
RANTES	415.43 ± 129.53	516.88 ± 113.65	0.54a
G‐CSF	8.02 [5.44–44.54]	6.52 [3.78–64.69]	0.78b
IL‐10/TNF‐α	0.63 [0.41–1.46]	0.10 [0.03–1.10]	0.07b

Data expressed as median [first quartile; third quartile] or as mean ± SEM; n = 5–9 per group.

^aStudent's t‐test.

^bMann–Whitney test.